Real-World Outcomes of Elexacaftor/Tezacaftor/Ivacaftor in Children with Cystic Fibrosis [0.03%]
Elexacaftor/Tezacaftor/Ivacaftor在囊性纤维化患儿中应用的现实世界结局分析
Lucy Perrem,Paul McNally
Lucy Perrem
Deployment Exposures, Respiratory Symptoms, and the Limits of Resting Lung Function [0.03%]
部署暴露、呼吸系统症状和静息肺功能的限制
Lauren M Zell-Baran,Cecile S Rose
Lauren M Zell-Baran
Safe and Timely Removal of a Fractured Tracheostomy Tube with the Use of a Controlled Radial Expansion Balloon [0.03%]
使用控制性经皮气管切开扩张球囊取出断裂的气管切开套管
Himmat Grewal,Zainab Abdulsada,Ramsy Abdelghani
Himmat Grewal
Occupational Exposure to Ambient Air Pollution: At-Risk Worker Groups, Regulatory and Research Needs An Official American Thoracic Society Workshop Report [0.03%]
职业性环境空气污染暴露：高危职业人群、监管及研究需求 美国胸科协会官方报告摘要
Maeve G MacMurdo,Lisa A Maier,John R Balmes et al.
Maeve G MacMurdo et al.
Although health effects of ambient air pollution are well established in the general population, the impact of exposure in working populations remains poorly understood. Outdoor workers are disproportionately exposed to ambient air pollutio...
Pulmonary Vascular Features on CT Chest Differentially Associate with Adverse Outcomes in Smokers in COPDGene [0.03%]
基于COPDGene研究的吸烟者肺血管CT特征与不良结局相关性分析
Shelsey W Johnson,Pietro Nardelli,James C Ross et al.
Shelsey W Johnson et al.
Background: In smokers with and without COPD, the differential strengths of association between chest computed tomography (CT)-based metrics of pulmonary vascular disease and adverse outcomes are unknown. ...
Changes in Airway Sampling and Pseudomonas Aeruginosa Isolation after the Introduction of Elexacaftor/Tezacaftor/Ivacaftor [0.03%]
Elexacaftor/Tezacaftor/Ivacaftor上市后的呼吸道标本采集变化及铜绿假单胞菌分离情况
John A King,Dominic Fenn,Micaela Mossop et al.
John A King et al.
Background: The impact of Elexacaftor/Tezacaftor/Ivacaftor (ETI) on provision of airway samples, chronic infection definitions, and Pa isolation frequency/abundance in those with established chronic Pa infection pre-ETI i...
Mental Health Diagnosis and Medication Changes After Initiation of Elexacaftor/Tezacaftor/Ivacaftor [0.03%]
Elexacaftor/Tezacaftor/Ivacaftor治疗后精神健康诊断和用药的变化
Cameron J McKinzie,Casey R Tak,Stephanie Duehlmeyer et al.
Cameron J McKinzie et al.
Rationale: Elexacaftor/tezacaftor/ivacaftor (ETI) has been associated with varied effects on mental health (MH) in people with cystic fibrosis (PwCF). Currently published literature has focused primarily on MH diagnoses/s...
Effect of a Self Directed Lifestyle-based Weight Management Program among Patients with Comorbid COPD and Sleep Apnea: A Secondary Analysis of the INSIGHT COPD Trial [0.03%]
针对合并COPD和睡眠呼吸暂停患者的生活方式体重管理项目的自我指导方案的有效性：INSIGHT COPD试验的二次分析
Aristotle G Leonhard,Scott Coggeshall,Emily Gleason et al.
Aristotle G Leonhard et al.
Rationale: Excess weight contributes to impaired physical function among individuals with chronic obstructive pulmonary disease (COPD) and sleep apnea. Self-directed lifestyle-based weight management programs are an acces...
Community-Acquired Pneumonia in Vulnerable Populations Across the Americas: Ongoing Barriers to Prevention and Management [0.03%]
美洲弱势群体中的社区获得性肺炎：预防和管理的持续障碍
Georgios D Kitsios,Marcos I Restrepo,Todd W Karsies et al.
Georgios D Kitsios et al.